Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 13, 2024.
All times in Eastern Daylight Time.
-
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common StockWILMINGTON, Del.--(BUSINESS WIRE)--Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock more »
-
Leading Independent Proxy Advisory Firm ISS Recommends Xperi Stockholders Vote “FOR” All Company Nominees on the BLUE Proxy CardSAN JOSE, Calif.--(BUSINESS WIRE)--Xperi Inc. (NYSE: XPER) (the “Company” or “Xperi”) today announced that leading proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended tha... more »
-
WisdomTree Sends Letter to Stockholders Outlining Board of Directors’ Essential Balance of Skillsets, Expertise and Institutional KnowledgeNEW YORK--(BUSINESS WIRE)--The Board of Directors of WisdomTree, Inc. (NYSE: WT), a global financial innovator, today issued a letter urging its stockholders to vote “FOR” all nine highly qualified... more »
-
Ajax Therapeutics Raises $95 Million Series C Financing To Advance First-in-Class Type II JAK2 Inhibitor, AJ1-11095, Into The ClinicNEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ajax Therapeutics, Inc., a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), t... more »
-
Moving iMage Technologies Third Quarter Fiscal 2024 Results Conference Call and WebcastFOUNTAIN VALLEY, Calif.--(BUSINESS WIRE)--Moving iMage Technologies (NYSE American: MITQ) will host a conference call discussing financial and operational results for its third quarter fiscal 2024 ... more »
-
CHANDLER, Ariz.--(BUSINESS WIRE)--Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) announced today that it intends to hold one or more meetings with potential investors with respect to a po... more »
-
Get in on the Bonus Action at Juicy Stakes CasinoST JOHN’S, Antigua--(BUSINESS WIRE)--Want to receive big bonus cash on some of the most popular diamond and gem-themed slots? Then head to Juicy Stakes Casino right now... From today (Monday 13 May... more »
-
GemaTEG™ lancia DaTEG 1.0: una soluzione innovativa per la gestione termica di server IABELLEVUE, Washington--(BUSINESS WIRE)--GemaTEG™ lancia DaTEG 1.0, una soluzione per la gestione termica che riduce notevolmente i costi energetici e migliora le prestazioni dei chip in infrastruttu... more »
-
DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced it has been selected by the Texas Department of Transportation (TxDOT) to provide pro... more »
-
Avery Dennison Announces Upcoming Investor EventsMENTOR, Ohio--(BUSINESS WIRE)--Avery Dennison Corporation (NYSE: AVY) today announced the company will be participating in the following upcoming investor events: BMO’s Farm to Market and Chemicals... more »
-
LONDRES--(BUSINESS WIRE)--Patron Capital, inversor institucional paneuropeo centrado en inversiones respaldadas por activos inmobiliarios, ha cerrado su séptimo fondo de referencia, recaudando más ... more »
-
Kenvue Announces Launch of Secondary OfferingSKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue announced today the launch of a secondary underwritten public offering of 182,329,550 shares of its common stock. more »
-
LONDRA--(BUSINESS WIRE)--Patron Capital, un investitore istituzionale paneuropeo specializzato in investimenti immobiliari, ha chiuso il suo settimo fondo principale, raccogliendo più di 860 milion... more »
-
Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk MelanomaRAHWAY, N.J.--(BUSINESS WIRE)--Merck Update on KeyVibe-010 Evaluating Coform of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients W/ Resected High-Risk Melanoma more »
-
TOKYO--(BUSINESS WIRE)--SQUARE ENIX HOLDINGS CO., LTD. (the “Company”) today announced consolidated financial results for the fiscal year ended March 31, 2024 (this “Fiscal Year”). The Company is l... more »